These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7636302)

  • 21. Effects of topical antiandrogen and 5-alpha-reductase inhibitors on sebaceous glands in male fuzzy rats.
    Ye F; Imamura K; Imanishi N; Rhodes L; Uno H
    Skin Pharmacol; 1997; 10(5-6):288-97. PubMed ID: 9449168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion.
    Goldstein JA; Socha-Szott A; Thomsen RJ; Pochi PE; Shalita AR; Strauss JS
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):760-5. PubMed ID: 6461679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. delta 5-3 beta-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male-pattern baldness.
    Sawaya ME; Honig LS; Garland LD; Hsia SL
    J Invest Dermatol; 1988 Aug; 91(2):101-5. PubMed ID: 3165109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.
    Délos S; Iehlé C; Martin PM; Raynaud JP
    J Steroid Biochem Mol Biol; 1994 Mar; 48(4):347-52. PubMed ID: 8142312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.
    Chen W; Zouboulis CC; Orfanos CE
    Dermatology; 1996; 193(3):177-84. PubMed ID: 8944337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris.
    Ganceviciene R; Graziene V; Fimmel S; Zouboulis CC
    Br J Dermatol; 2009 Feb; 160(2):345-52. PubMed ID: 19077080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased androgen binding capacity in sebaceous glands in scalp of male-pattern baldness.
    Sawaya ME; Honig LS; Hsia SL
    J Invest Dermatol; 1989 Jan; 92(1):91-5. PubMed ID: 2909628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotretinoin treatment upregulates the expression of p53 in the skin and sebaceous glands of patients with acne vulgaris.
    Agamia NF; El Mulla KF; Alsayed NM; Ghazala RM; El Maksoud REA; Abdelmeniem IM; Talaat IM; Zaki II; Sabah RM; Melnik BC
    Arch Dermatol Res; 2023 Jul; 315(5):1355-1365. PubMed ID: 36585988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in serum free testosterone, sleep patterns, and 5-alpha-reductase type I activity influence changes in sebum excretion in female subjects.
    Bissonnette R; Risch JE; McElwee KJ; Marchessault P; Bolduc C; Nigen S; Maari C
    Skin Res Technol; 2015 Feb; 21(1):47-53. PubMed ID: 25163854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands?
    Karlsson T; Vahlquist A; Kedishvili N; Törmä H
    Biochem Biophys Res Commun; 2003 Mar; 303(1):273-8. PubMed ID: 12646198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ hybridization analysis of CRABP II expression in sebaceous follicles from 13-cis retinoic acid-treated acne patients.
    Sitzmann JH; Bauer FW; Cunliffe WJ; Holland DB; Lemotte PK
    Br J Dermatol; 1995 Aug; 133(2):241-8. PubMed ID: 7547391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal control of 5 alpha-reductase activity in hamster sebaceous glands.
    Takayasu S; Itami S
    Endocrinol Jpn; 1982 Feb; 29(1):95-8. PubMed ID: 7106062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hair follicles and associated glands as androgen targets.
    Ebling FJ
    Clin Endocrinol Metab; 1986 May; 15(2):319-39. PubMed ID: 3521958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11β-hydroxysteroid dehydrogenase type 1 is expressed in human sebaceous glands and regulates glucocorticoid-induced lipid synthesis and toll-like receptor 2 expression in SZ95 sebocytes.
    Lee SE; Kim JM; Jeong MK; Zouboulis CC; Lee SH
    Br J Dermatol; 2013 Jan; 168(1):47-55. PubMed ID: 22897663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranuclear androgen concentrations in facial skin.
    Kurata S; Itami S; Komada S; Sonoda T; Takayasu S
    J Dermatol Sci; 1991 Mar; 2(2):75-8. PubMed ID: 2065001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse.
    Park WS; Lee CH; Lee BG; Chang IS
    J Dermatol Sci; 2003 Apr; 31(2):91-8. PubMed ID: 12670719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional difference in sebum production by androgen susceptibility in human facial skin.
    Seo YJ; Li ZJ; Choi DK; Sohn KC; Kim HR; Lee Y; Kim CD; Lee YH; Shi G; Lee JH; Im M
    Exp Dermatol; 2014 Jan; 23(1):70-2. PubMed ID: 24289322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropeptides and sebaceous glands.
    Toyoda M; Nakamura M; Morohashi M
    Eur J Dermatol; 2002; 12(5):422-7. PubMed ID: 12370127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable androgen sensitivity in relationship to hirsutism and acne.
    McKenna TJ
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):547-9. PubMed ID: 8252743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.